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Staphylococcus aureus is a major cause of prosthetic joint infection (PJI) in which it forms 
adherent biofilms, thick aggregates of extracellular polymeric substances (EPS) produced by the 
bacteria. Biofilm associated infections are difficult to treat as they have increased resistance to 
various antimicrobial agents, which means infected implants often require multiple procedures 
and prolonged antibiotic therapy. However, a new and emerging method of treatment of PJI is 
non-contact induction heating (NCIH) of metal implants. We sought to investigate the feasibility 
and effectiveness of NCIH along with synergistic effects of antibiotics (Vancomycin) in reducing 
bacterial load within surface associated biofilms in vitro on stainless steel and titanium washers.   
Our preliminary results support the hypothesis that NCIH of metal implants is effective in 
reducing bacterial load of S. aureus within a biofilm in vitro. In our study, the synergistical use 
of the dual treatment strategy (heat and antibiotics) resulted in a ~1000-fold total decrease in 
CFUs/ml (~3 log reduction). This suggests the potential synergistic effect between the heat and 
antibiotic treatment against biofilms. These results can be further explored as a new treatment 
modality for PJI and infections of orthopedic implants. Future work in this study will investigate 
if NCIH can be used synergistically with antibiotics to more effectively eliminate biofilm 
associated infections. 
Keywords - Prosthetic joint infection (PJI), Total Joint Replacement, Induction heating, Biofilm, 







Summary for Lay Audience  
One of the most challenging complications after total joint replacement surgery is 
periprosthetic joint infections (PJI). Staphylococcus aureus is the bacteria responsible for the 
majority of these infections. One of the reasons that these infections are challenging to treat 
either with antibiotics or surgically with the present standard of care practices is that the residing 
bacteria form a “slime” like layer, called biofilms on the surfaces of the implants and the 
adjacent periprosthetic tissue. Biofilm associated infections are difficult to treat as they have 
increased resistance to various antimicrobial agents, which means infected implants often require 
multiple surgical procedures and prolonged antibiotic therapy. However, a new and emerging 
method of treatment of PJI is non-contact induction heating (NCIH) of metal implants. We 
sought to investigate the feasibility and effectiveness of NCIH of metal implants along with 
antibiotics in reducing bacterial load within surface associated biofilms in vitro. These 
preliminary results support the hypothesis that NCIH of metal implants is effective in reducing 
bacterial load of S. aureus within a biofilm in vitro. These results can be further explored as a 
new treatment modality for PJI and infections of orthopedic implants. Future work in this study 
will investigate if NCIH can be used synergistically with antibiotics to more effectively eliminate 
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Chapter 1 – Introduction 
 
1.1 Introduction to Staphylococcus aureus biofilms and infection  
 
A biofilm is defined as a sessile microbial community in which cells are attached to a 
surface or to other cells and embedded in a protective extracellular polymeric matrix (1). Biofilms 
act as environmental reservoirs for pathogens, and growth within a biofilm may provide organisms 
with survival advantages in natural environments and increase their virulence. Staphylococcus 
aureus is a gram-positive commensal bacterium that persistently colonizes the anterior nares of 
approximately 20– 25% of the healthy adult population and is the second most frequent cause of 
nosocomial blood infections. Approximately 80% of nosocomial infections caused by S. aureus 
are due to colonization by the same strain (2). Ellis et al.(3) report that that nasal colonization does 
not appear to be the only  requirement for community-associated S. aureus related infection  and  
other factors such as different  anatomic sites, person-to-person spread, and fomites are likely 
important factors as well. 
S. aureus is known to cause a diverse range of acute and chronic infections. For instance, 
acute  bacteremia and skin abscesses, are caused by planktonic cells through the production of 
secreted toxins and exoenzymes (4). Chronic infections are linked with a biofilm mode of growth 
where S. aureus attaches and persist on host tissues, such as bone and heart valves, to cause 
osteomyelitis and endocarditis respectively or on medical  and surgical implants, such as catheters, 







1.1.1 MRSA and CA- MRSA (USA 300) 
 
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of morbidity 
and mortality in hospitals globally. MRSA is endemic in North America and has also been involved 
in epidemiologically unassociated outbreaks of skin and soft tissue infections in healthy 
individuals in at least 21 US states, Canada and Europe (8).  Methicillin resistance in S. aureus is 
defined as an oxacillin minimum inhibitory concentration (MIC) of greater than or equal to 4 
micrograms/mL (5). Healthcare-associated MRSA infections occur in individuals with 
predisposing risk factors for diseases, whereas community-associated MRSA (CA-MRSA) 
infections often occur in healthy individuals. CA-MRSA infections are known to be epidemic in 
some countries and are more virulent and transmissible than traditional hospital-associated MRSA 
strains (6). In addition to enhanced virulence, some CA-MRSA strains such as USA300 have the 
ability to spread readily (6). Ellis et al. (3) reported that  USA300 MRSA colonization with MRSA 
associated skin and soft tissue infection is relatively uncommon,  but when it does occur, it appears 
to be playing a role in pathogenesis. 
 
1.2 Clinical significance  
 
Biofilm associated infection is one of the most common causes for failure of orthopedic 
implants and cause extensive morbidity, high cost of care, and tremendous socioeconomic burden 
(7). The infection burden associated with total hip and knee arthroplasty is low, with estimates 
ranging from around 1% to 2% (8). The 5-year survival rate associated with PJI (87.3%) is worse 






(9). All the materials used in orthopedic implants are vulnerable to attachment of biofilm forming 
bacteria, which places these implants at risk for surgical site infections (SSIs). Pathogenesis of 
biofilm associated implant-related infections develops after pathogens attach to the protein 
conditioned surface, which is known to occur intraoperatively, post operatively, and on a delayed 
basis. Present standard of care strategies include antibiotic suppression, debridement with retention 
of prosthesis (DAIR) (10, 11), excision arthroplasty including single-stage revision (11), or two-
stage revision (12), multiple- stage revision; partial revision (13) and arthrodesis. The reported  
overall infection-free survivorship for two-stage revision TKA was 85% at 5 years and 78% at 10 
years (14). More than 25% of revision surgeries are attributed to PJI and in  many cases, multiple 
revision surgeries for failed eradication of PJI result in amputation or death. (7) 
 
1.2.1 Diagnostic and therapeutic challenges  
 
Most common signs and symptoms of periprosthetic joint infection ( PJI)  include local or 
diffused pain, joint swelling or effusion, erythema or warmth around the joint, fever, drainage, 
implant loosening or the presence of a sinus tract communicating with the joint , but a few cases 
can also present with few symptoms or signs (7, 15). With currently available diagnostic tests, 
clinical diagnosis can be challenging unless the dispersed microorganism is virulent enough to 
incite a host response. Biofilm bacteria are challenging to diagnose because, they often do not 
grow by routine culture resulting in a high false-negative rate, absence of definitive biofilm 
biomarkers and absence of specific imaging modality that can directly detect biofilms (16). 
Sensitivity of conventional microbiologic culture methods can be low, due to the inability of 
microorganisms to propagate in the sessile phenotype. Inability to isolate and identify the causative 






lead to continuation of the infection and higher chances of persistence of infection following 
revision surgery.   
 
1.2.2  PJI - Periprosthetic Joint Infections 
Joint replacement arthroplasty is a highly effective intervention that improves the quality 
of life of the patient, relieves symptoms, restores joint function, and improves mobility and 
independence in patients with severe osteoarthritis, inflammatory arthritis, post-traumatic arthritis 
and many conditions that affect the articular surfaces (17). There is an increasing volume of 
primary joint arthroplasties, with a projected annual volume of more than 4 million cases by 2030 
in the United States. The economic burden of treating infected revisions is estimated to be$1.62 
billion in the United States by2020 (18). Despite global efforts to reduce postoperative infection, 
infection burden has actually increased worldwide, based on publicly reported data from 6 
arthroplasty registries (8). 
 PJI associated with biofilms in particular, prove difficult to treat and the optimal surgical 
and antibiotic treatment of PJI is unclear (19, 20). One of the reasons that these infections are so 
difficult to treat by a single round of antibiotic therapy alone is that the residing bacteria form 
biofilms on the surfaces of the implants and the adjacent periprosthetic tissue (21).  
  
1.2.3 Biofilm –Pathogens forming biofilm  
Bacterial biofilms can be formed by gram-positive or gram-negative, motile or nonmotile, 
rapid or slow growing, and aerobic, facultative, or anaerobic species (22). All of the common 
pathogens associated with PJI have been shown to form biofilm by in vitro experiments or by ex 






Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas 
aeruginosa, and Enterobacter species as well as low-virulence pathogens such as Cutibacterium 
(formerly Propionibacterium) acnes and coagulase-negative staphylococci such as Staphylococcus 




1.3 Biofilm -   Stages of development  
 
The life cycle of biofilm is a complex continuum progressing through four stages (21): (1) 
Attachment -interaction between bacteria and the implant; (2) Accumulation -interactions between 
bacterial cells ,where cells on the surface begin to transition from the planktonic (free floating) to 
the biofilm phenotype where they begin to produce  extracellular polymeric substance (EPS)  and 
undergo cell division to produce small aggregates and clusters; (3) Maturation -formation of a 
viable 3D structure in which the structures are large enough to develop distinct 
microenvironments; (4) Dispersion –bacteria detachment from the biofilm. The timeline of biofilm 
development is variable depending on the organism involved (Figure 1). 
 






1 - Initial Attachment - During initial attachment, an individual planktonic cell will 
reversibly associate with a surface, and if the cell does not dissociate, it will bind irreversibly to 
the surface. Attachment is mediated through surface proteins, referred to as microbial surface 
components recognizing adhesive matrix molecules (MSCRAMMs) (25). The fibronectin-binding 
protein A and B (FnBPA, FnBPB), the collagen-binding protein Cna and the fibrinogen-binding 
proteins, clumping factor A and B (ClfA and ClfB), belong to this family (26, 27). During 
infection, these proteins play major roles in attachment to host factors such as fibrinogen, 
fibronectin, and collagen. Biofilms in PJIs can form on all types of orthopedic components, as well 
as accessory materials such as sutures and bone cements, regardless of the construction material 
(28). 
 2- Accumulation and early biofilm formation - Once bacteria are attached, they produce 
an extracellular polymeric substance (EPS), which can vary from species to species and even 
between strains. On the surface begin to transition from the planktonic (free floating) to the biofilm 
phenotype where they begin to produce EPS and undergo cell division to produce small aggregates 
and clusters (23). Cells in the nascent biofilm can also undergo autolysis, releasing extracellular 
DNA (eDNA) which has been shown to play a structural role in biofilm EPS.  Furthermore, these 
polymers can interact through polymer entanglement, electrostatic interactions, and cross-linking 
to form complex polymer networks. 
3- Maturation - As cells divide and EPS is formed, the biofilm structures become larger 
and develop a three-dimensional architecture which leads to the development of 
microenvironments, combined with structural stability. Ex vivo microscopic examination of 
clinical specimens from orthopedic infections reveals that biofilms usually appear as aggregates 






studies have shown that although there can be fluid flow in channels around the biofilm structure 
within the EPS matrix itself, there is no advective flow and mass transfer is limited by diffusion. 
As the biofilms become thicker, this diffusion limitation results in sharp gradients building up 
within biofilms as nutrients (i.e., glucose and oxygen) are consumed by respiring bacteria on the 
periphery of the aggregates faster than they can diffuse inward. Similarly, metabolites such as cell 
signalling molecules used to coordinate behavior between individual cells in a population and 
waste products, such as acids from fermentation, produced by cells in the interior of the biofilm 
can build up. Thus, the periphery of the biofilm might be in a normal physiological range while 
bacteria within a 100 μm may be in an anaerobic and acidic environment (29). 
4. Dispersal – Dispersal is the last stage in the lifecycle of the biofilm. When biofilms get 
starved, they can initiate dispersal through cell signaling pathways to use different mechanisms 
such as the production of hydrolases that degrade EPS polysaccharides in the case of P. aeruginosa 
or the production of surfactants (PSM) in the case of S. aureus (30, 31). Most of the time, biofilms 
remain localized to an area and generally do not tend to spread; however, dispersal events may 
explain periodic acute episodes of sepsis. Biofilm can either be found adherent to a surface or as 
floating aggregates over a time period that ranges from minutes to hours in vitro, and days to weeks 
or longer in vivo (32). 
Biofilms can mature before they present diagnosable findings, because it is the host 
response to bacteria outside of biofilms that leads to clinical symptoms, physical findings, and 
positive diagnostic tests. This limits the opportunity to intervene before the biofilm is established. 
In vitro experiments and in vivo animal studies report that progression of biofilms is mediated by 
the interplay of a number of microbial, host, and environmental factors (21), and the timeline for 







1.3.2 Biofilm – Structure Matrix  
The S. aureus biofilm matrix is a complex glue that encases all of the cells in the mature 
structure, and it is thought to be composed of host factors, secreted and lysis-derived proteins, 
polysaccharide, and eDNA. A major constituent of the biofilm matrix is polysaccharide 
intercellular adhesin (PIA), also known as poly beta-1,6-N-acetyl-D-glucosamine (PNAG) (33). 
The PIA polymer plays an important role in the structural integrity of biofilms in vitro and in vivo. 
PIA is an important component in both S. aureus and S. epidermidis biofilms and is produced by 
enzymes encoded in the icaADBC locus. It is composed of β-1,6-linked N-acetylglucosamine 
polymer, and the proteins encoded in the ica locus are responsible for the synthesis, export, and 
modification of PIA. Numerous studies have identified S. aureus strains capable of forming ica-
independent biofilms made up of proteins and eDNA, which act as intercellular adhesins in the 
absence of PIA (34-36). Due to the negative charge of the DNA polymer, eDNA potentially acts 
as an electrostatic polymer that anchors cells to a surface, to host factors, and to each other.  Early 
biofilms are most sensitive to DNase treatment, suggesting that eDNA may be important during 
attachment (37).  
 
1.3.3 Quorum sensing (Role of glucose in vitro and agr)  
 
Intercellular signaling, often referred to as quorum sensing, has been shown to be 
involved in biofilm development by several bacteria (38). The S. aureus quorum-sensing system 
is encoded by the accessory gene regulator (agr) locus and the communication molecule that it 






that the agr quorum-sensing system is involved in biofilm detachment. This study demonstrated 
that bacteria dispersing from biofilms displayed high levels of agr activity, while cells in a 
biofilm had predominantly repressed agr systems forming more robust biofilms compared to 
wild types strains (40).  Furthermore, Boles et al.(41) suggested a role for the agr system in S. 
aureus biofilm  development, as agr mutants exhibit a high propensity to form biofilms and that   
repression of agr is necessary to form a biofilm and that reactivation of agr in established 
biofilms through AIP addition or glucose depletion triggers detachment. Additionally, Regassa et 
al. also reported that growth on rich media containing glucose represses the agr system through 
the no maintained generation of low pH (42). 
 
1.3.4 Surface Properties for Biofilm formation  
 
The physicochemical properties of  implants that are known to affect the time required and 
robustness of the established biofilms include surface chemistry, surface charge, 
hydrophilicity/hydrophobicity, micro/nano-topography, and porosity (43, 44). In vitro experiments 
and in vivo animal models have found that modification of implant surface can decrease bacterial 
adherence, and thus decrease biofilm formation leading investigators to seek physico-chemical 
surface modifications and coatings to inhibiting bacterial adhesion to theoretically decrease the 
risk of infection without limiting osseointegration (45). However, biofilms can form on almost 







1.4   S. aureus Biofilm-Related Diseases  
S. aureus has been known to infect and form a chronic biofilm infection most often on 
orthopedic implants including prosthetic joints, wires, pins, external fixators, plates, screws and 
nails (46). Other medical devices that are prone to biofilm infection include stents, ventilators, 
intravenous catheters, invasive blood pressure units, infusion pumps, cardiac defibrillators, 
mechanical heart valves, aspirators, pace makers and cosmetic surgical implants. During cases of 
implant infection, the infection can occur during implantation, subsequent trauma or 
hematogenous seeding, as the surface of implant becomes coated with host derived extracellular 
matrix proteins, providing a rich surface for bacterial attachment (46). 
 
1.5 Diagnosis of a biofilm  
Commonly used tests or techniques available to diagnose PJI including either the direct 
method or the indirect method. The direct method involves laboratory isolation of the pathogen 
responsible for the PJI through either aspirate or tissue samples. Biofilm bacteria can be difficult 
to culture because of poor isolation and poor growth characteristics due to relatively dormant 
persisters and small colony variants (47). Some of the possible solutions for improving the 
isolation of these bacteria include the use of sonication of retrieved implants (48), as well as use 
of methods such as polymerase chain reaction (PCR), which help in tackling poor growth 
characteristics without depending on pathogen growth or culture.(49) 
 The indirect method includes some of the tests related to the host response to infection 
without the isolation of the actual pathogens. These indirect tests include the following: 






neutrophil percentage (50), leukocyte esterase (51), alpha-defensin(52), d-dimer (53) and histology 
(neutrophils per high-powered field). Unfortunately, there is no single accepted set of diagnostic 
criteria as yet for PJI and in certain low-grade infections eg. Cutibacterium acnes, several of these 
criteria may not be routinely met despite the presence of PJI (38). 
 
1.6.1 Management strategies for S. aureus biofilm infections  
There are many management strategies and protocols to treat PJI, which need to be 
individualized to each patient to maximize success. This can be in the form of antibiotic 
suppression; debridement with retention of prosthesis (DAIR);(10, 11) or excision arthroplasty 
including single-stage revision (11), two-stage revision(12), multiple- stage revision, partial 
revision, and even arthrodesis or amputation (13). Use of cement or calcium sulfate beads has 
shown some efficacy in preventing infection via inclusion of an antimicrobial agent at the site of 
infection, which provide a  rapid release of high concentrations of antibiotics at the wound site 
(54). Calcium sulfate beads also dissolve and so do not require surgical removal. The antibiotic 
selected for inclusion in beads must be active against the causative microbes & available as a 
powder that will harden properly and able to maintain activity despite the heat generated during 
the polymerization process (55). The majority of the agent is released in a biphasic manner, in the 
first few hours to days after implantation, with the remainder leaching out slowly over a matter of 
weeks, months or in some cases, years (56). Elution rates depend on conditions such as eluent 
solvent and pH. The elution characteristics of specific antibiotics vary depending on cement type, 
although Palacos cement provides more complete elution of most agents, including the commonly 






The majority of present treatment strategies are maximally invasive therefore, impossible 
in patients with high comorbidities. Furthermore, the increasing antibiotic resistance of bacteria 
raises concern and limits the choices of antibiotics (58, 59). Therefore, it is vital that novel, non-
invasive management options such as non-contact induction heating of metallic implants  for the 
prevention and treatment of biofilm infections in implants are developed to reduce the burden of 
more invasive and extensive revision surgeries and possibly improve effectiveness of present 
standard of care practices. 
1.6.2 Antibiotic resistance and tolerance 
Antibiotic resistance generally means an increase in the minimum inhibitory 
concentration (MIC) value of an antibiotic due to a permanent change in the bacteria. Antibiotic 
tolerance, on the otherhand, is the ability of cells to survive the effect of an antibiotic due to a 
reversible phenotypic state (60). The use of these definitions is well suited for planktonic cells, 
but for biofilms, it is used in a different context. In biofilms, antimicrobial tolerance is related to 
the mode of growth of the biofilm. This is different from bacteria growing in planktonic culture, 
which, usually, will show susceptibility to antimicrobials (61). Biofilm formation is the natural 
state for the vast majority of bacteria in vivo. Therefore, antibiotic tolerance is a natural state of 
biofilms. Also, antibiotic resistance is a natural phenomenon, since bacteria have evolved to 
resist the action of natural antibacterial products for billions of years in the absence of human 
activity (62). 
Antibiotic tolerance has been reported for a diverse number of bacterial species for a wide 






is well above the therapeutic window of what can be achieved systemically (23). Main factors 
promoting biofilm-specific antibiotic tolerance/ resistance include: 
1 -Bacterial dormancy-   limitation of nutrients inside biofilm, can lead the bacteria to go 
into a slow growing or dormant phenotype and thus are not engaging in cellular processes (i.e., 
cell wall synthesis, protein synthesis, DNA replication) which are interrupted by conventional 
antibiotics which are otherwise effective against rapidly growing cells. 
 
2- Biofilm Thickness – In order to penetrate the cells within the biofilm, antibiotics have 
to penetrate the EPS slime matrix. The time to diffuse into the biofilm is proportional to the square 
of the distance traveled, which depends on the thickness of the biofilm. In addition to diffusion, 
limitation cationic antibiotics such as tobramycin and vancomycin (two commonly used antibiotics 
added to bone cement) have been shown to bind with anionic components (polysaccharides and 
eDNA) in the EPS further hindering transport into P. aeruginosa and S. epidermidis biofilms. In 
these studies, and other studies, subminimum inhibitory concentrations (sub-MIC) of antibiotics 
have been shown to stimulate the production of biofilm or EPS components such as eDNA, 
presumably as a defense mechanism (16, 63). 
3- Persister cells – Bacterial cells may escape the effects of antibiotics without 
undergoing genetic change; these cells are known as persisters. Unlike resistant cells that grow in 
the presence of antibiotics, persister cells do not grow in the presence of antibiotics. These 
persister cells are a small fraction of exponentially growing cells (due to carryover from the 
inoculum) but become a significant fraction in the stationary phase and in biofilms (up to 1%). 
Critically, persister cells may be a major cause of chronic infections (47).  These persister cells 






cells enter a dormant state regardless of nutrient availability and appear to be responsible for the 
resistant nature of chronic infections, since antibiotics kill the majority of cells. However, 
persisters remain viable and repopulate biofilms when the level of antibiotics drops (47). 
Quorum-sensing (Q-S) regulates several factors that contribute to biofilm formation and 
persistence. Q-S is involved in the production of eDNA, which inhibits the penetration of some 
antibiotics into the Biofilm. Since there is no indication that Q-S promotes antibiotic tolerance in 
planktonic cells, this mechanism maybe biofilm-specific (61). 
4- Sub-minimum inhibitory antibiotic concentration -Sub-minimum inhibitory 
concentrations of a variety of antibiotics were found to induce biofilm formation in a number of 
phylogenetically diverse Gram-positive and Gram-negative bacteria in vitro (64). It is likely that 
some bacterial cells in biofilm are exposed to sub-MIC levels of antibiotics during antimicrobial 
chemotherapy due to falling concentrations by dilution or diffusion gradients for antibiotics in 
biofilm. Sub-MICs of antibiotics can induce mutagenesis, which confers resistance to other 
antibiotics (65). 
 
1.6.3    Present management options for biofilm related periprosthetic joint infections  
 
There are many therapeutic strategies to treat PJI, which need to be tailored to each patient 
to maximize success. It is essential to have a multidisciplinary approach between microbiologists, 
surgeons, and infectious disease departments to yield the best outcome in these challenging 
situations (16). There are many management strategies and protocols to treat PJI, which need to 
be individualized to each patient to maximize success. This can be in the form of antibiotic 






including single-stage revision (11), or two-stage revision (12), multiple- stage revision, partial 
revision (13) and even arthrodesis and, if necessary, amputation. The majority of present treatment 
strategies are maximally invasive  therefore, impossible in patients with high comorbidities along 
with the increasing antibiotic resistance of bacteria, raises concern and limits the choices of 
effective antibiotics (58, 59). Therefore, it is paramount that alternative modalities of biofilm 
treatment and eradications of infections in orthopaedic implants are developed. 
 
1.7. – Need for novel alternatives treatment options for biofilm management  
 
This subject was assigned to the Biofilm Workgroup during the second International 
Consensus Meeting on Musculoskeletal Infection held in Philadelphia, USA (ICM 2018) with 
representations of experts from around the world. The aim of the meeting was  to identify the best 
practices & develop research studies, dedicated to advancing our understanding of biofilms and 
their role in human implant-related infections. The consensus document suggested biomedical 
research funding agencies and the pharmaceutical industry should recognize these areas as a 
priority, for urgent development of  better diagnosis and eradication strategies (21). 
 
1.7.1- Effects of heat on biofilm  
 
In food preservation studies, heating has been reported to be an effective way to reduce the 
bacterial load of S. aureus (66). The effect of heat treatment on three physical properties of the 
biofilms: the bacterial cell morphology and viability, the polymeric properties of the extracellular 






properties of the bulk biofilm have been studied & observed to have an order of magnitude 
reduction in the biofilm yield stress after 60 °C temperature treatment. No such difference was 
found for treatment at 45 °C. From these results, it has been established that the yield stress of 
bacterial biofilms is temperature-sensitive, and that this sensitivity is correlated with cell viability. 
The yield stress is of particular interest, as it is a measure of how much force must be applied to 
an apparently solid material to get it to flow and show liquid-like behavior (67). 
 The observed significant decrease in yield stress with temperature suggests a means to 
weaken the mechanical integrity of S. epidermidis biofilms with applications in areas such as the 
treatment of biofilm-infected medical devices (67). 
 
1.7.2 Non-contact electromagnetic induction heating for eradicating biofilm  
 
Heating is an effective way to reduce the bacterial load in food preparation, and studies on 
hyperthermia treatment for cancer have shown that it is possible to heat metal objects with pulsed 
electromagnetic fields selectively (PEMF). Non-contact induction heating of a titanium disk is 
effective in reducing bacterial load in vitro (68). Log reduction of bacterial load were calculated 
using the following equation: log10(A/B), where A is the number of viable micro-organisms 
before the experiment in CFU/ml and B is the number of viable micro-organisms after the 
experiment in CFU/ml.  These promising results can be further explored as a new treatment 
modality for infections of metal orthopedic implants (68). 
 
1.7.3    PEMF 
Non-contact induction heating (NCIH) uses the principles of pulsed electromagnetic fields 






can be used to cause thermal damage to bacterial biofilms on the metal implant, hence, killing the 
bacteria and weakening the biofilm (68, 69). In the field of hyperthermia cancer treatment, several 
studies have shown the feasibility of induction heating of "thermal seeds" and nanoparticles (70).  
In the field of fracture healing with shape memory devices. Müller et al. (71) have also shown the 
feasibility and safety of contact-free electromagnetic induction heating of Nickel Titanium 
alloy (NiTi) implants in a rat model.   
Hence this novel application of heat can be used as an adjuvant to chronic suppressive 
antibiotic therapy or severely immunocompromised patients, who are not fit for surgery. The 
metal implant fixed to the bone can be heated noninvasively with care taken to avoid excessive 
heating to areas that are in close contact with important anatomical structures. Alternatively, 
NCIH can be used during surgery to increase the effectiveness of the surgical procedure such as 
in Debridement, Antibiotics and Implant Retention (DAIR), allowing heating of parts of the 
implant that cannot be reached and mechanically cleaned. During surgery, soft tissue can be 
protected by keeping it away from the heated part of the implant. 
 
1.7.4 Antibiotic synergy  
 
Since contemporary treatment methods such as surgical debridement with pulse lavage and 
antibiotics may not be effective once biofilm formation has reached a certain bioburden threshold, 
induction heating may prove to be a valuable addition to these treatments (72). Furthermore, the 
increasing resistance of bacteria to antibiotics raises concern and limits the choice of antibiotics 
(73). Hajdu et al.(74) have shown that the antibacterial activity of antimicrobial agents is 
significantly enhanced by increasing the ambient temperature. Pijls et al.(75) report that in 






whereas the cocktail of antibiotics diffuses into the biofilm starting at the outer border of the 
biofilm and ultimately ending at the biofilm–implant interface. This bi directional attack may be a 
mechanism for the observed synergistic effect that leads to total eradication (75). Thus, the PEMF 
may work synergistically with thermal damage and antibiotics. These synergistic effects require 
further investigations, since the future application of non-contact induction heating of metal 
implants, will likely be applied in a clinical setting where antibiotics are part of the treatment 
strategy (68). 
 
1.7.5 Concerns - Temperature elevation & effect on soft tissues 
 
There may be concerns for potential tissue necrosis with induction heating due to relatively 
high temperatures at the prosthesis-bone interface. Temperatures greater than 50°C (122°F) occur 
routinely during the process of intramedullary reaming as well as stimulation of revascularization 
by the breaking-up of intramedullary scar tissue (76, 77).There are also animal experiments that 
confirm the lack of necrosis after induction heating up to 60°C (71).  Samara et al. (78) have shown 
that bone cement, reaches temperatures of 80°C  for more than 10 min during the curing process. 
Additionally, special heating techniques such as segmental induction heating can be used to apply 
localized heating to a segment of an implant, using the remainder of the implant as a heat sink 
(79). The surrounding tissue is heated to some extent by thermal conduction from the heated metal, 
but if the tissue is well perfused by arterial and venous blood flow, the heat will very likely be 
significantly reduced as in coagulation procedures (80, 81). Since cemented prostheses have an 
excellent long-term track record in several national joint registries, the concern of necrosis due to 
temperatures of around 60°C from curing cement remain theoretical. Studies with bone cement 






bone readily exceed 60°C, hence induction heating at this 60°C temperature range should be safe 
which was found to be the most effective temperature in the present study (82, 83). 
1.8 Project Rationale  
Periprosthetic joint infection (PJI) is a devastating complication of surgery, often 
requiring multiple rounds of antibiotic therapy and surgeries to treat. Furthermore, the increasing 
resistance of bacteria to antibiotics raises concern and limits the choice of antibiotics (73). 
Contemporary treatment methods such as surgical debridement with pulse lavage and antibiotics 
may not be effective once biofilm formation has reached a certain bioburden threshold. This 
multidisciplinary study  between orthopaedics, microbiology and medical biophysics, will serve 
as a foundation to better understand biofilm related implant infections and develop novel 
strategies for its clinical management. 
Staphylococcus aureus is a major cause of prosthetic joint infection (PJI) in which it forms 
adherent biofilms. Biofilm associated infections are difficult to treat as they have increased 
resistance to various antimicrobial agents, which means infected implants often require multiple 
procedures and prolonged antibiotic therapy. Bacterial biofilm infections can be difficult to 
eradicate with antimicrobials (84). Furthermore, increasing antibiotic resistance of bacteria raises 
concern and limits choices of antibiotics (84). However, knowledge gaps exist in the potential role 
of physical methods such as heat, for biofilm treatment. Therefore, it is vital that novel treatment 
options such as NCIH are explored that improve outcome, reduce patient morbidity and mortality 
and can be effectively used   in the treatment of biofilm infections in implants. 
Studies dedicated to advancing our understanding of biofilms and implant-related 






emerging method of treatment of PJI is non-contact induction heating (NCIH) of metal implants. 
Hence we sought to investigate the feasibility and effectiveness of NCIH of metal implants in 
reducing bacterial load within surface associated biofilms in vitro (68). It is currently unknown 
whether NCIH can reduce or even eradicate S. aureus from the biofilm on stainless steel and 
titanium alloys, which are common metals used in orthopedic trauma and arthroplasty implants. It 
is important to evaluate the possible synergistic effect of NCIH and antibiotics, because NCIH will 
very likely be applied to a scenario in a clinical setting where antibiotics are part of the established 
treatment protocol and heat has been shown to enhance the antibacterial activity of antimicrobial 
agents against staphylococcal biofilm (74). 
This multidisciplinary collaboration study will help provide a better understanding of the 
environment of the biofilm and could lead to development of novel treatment strategies, which in 
the future can be applied for further validation via animal testing. 
 
1.9   Research objectives 
The purpose of this study was (1) to study the potential role of NCIH as a method for 
reducing bacterial load in a biofilm in-vitro model and (2) to investigate its synergistical use with 
antibiotics, to increase the effectiveness of antimicrobial therapy.  
 
Chapter 2 - Material and methods 
In order to advance our understanding of the role of biofilms in PJI, it is vital that novel 
treatment options such as NCIH and its possible synergistic effects with antibiotics are explored 









The purpose of the current study was (1) to design an in vitro model to test the effect of 
heating duration and temperature of non-contact induction heating stainless steel and titanium 
washers inoculated with S. aureus based mature biofilm to study the potential role of physical 
methods (heat) as a non-invasive method for the eradication of biofilm. (2) To determine the 
possible synergistic effects of non-contact heating with antibiotics (vancomycin). 
 
2.2 In Vitro Biofilm Growth  
 
2.2.1 Bacteria Strain and culture conditions  
 
 S. aureus strain USA300 was used throughout this study due to its association with 
implant-based infections. CA-MRSA strains such as USA300 have the ability to spread readily 
(6). It has been involved in epidemiologically unassociated outbreaks of skin and soft tissue 
infections in healthy individuals in at least 21 US states, Canada and Europe (85). These micro-
organisms were chosen as representatives  of  gram-positive  bacteria,  associated with infections 
of orthopedic implants, as S. aureus is a major cause of hospital acquired  & implant associated 
infections (86). 
 The bacteria were grown overnight in 5mL cultures of tryptic soy broth (TSB) and 600µL 
was pelleted by centrifuging and then normalized to an OD600 of 1.0 in 1mL of sterile saline. 






13mm x 1.5 mm x6.6mm, used with 4.5 - 7.3 mm diameter screws and manufactured from stainless 
steel and titanium), were sterilized by autoclaving and placed into the wells of a 12 well tissue 
culture plate (Figure 2). The wells containing washers were then filled with TSB and inoculated 
with S. aureus at an OD600 of 0.01 and 0.4% glucose was added to the growth media (TSB-G) to 
stimulate biofilm formation as per earlier work done by Boles et al.(41). The plates were then 
incubated statically at 37ºC for 24 hours to allow the biofilms to grow. 
 
2.3.2 Non-Contact Heating  
The stainless steel and titanium washers were exposed to a PEMF from an induction cooker 
(Master Chef Induction Hot Plate ,1800W) after contamination. An induction cooker was chosen 
because several studies have indicated that the PEMF generated by induction cookers, on the order 
of 20 kHz to 30 kHz, is safe for humans for non-contact temperature  measurement (87). The 
cooktop had been modified in order to automatically activate and deactivate to maintain the heating 
of the washers at a specified target temperature. Multiple trials were done to check the maximum 
temperature attained by the washers when heated to the maximum capacity of the induction heater. 
Due to physical limitations such as the size and shape of the washers/ induction heater, the 
maximum temperature that could be reliably maintained was 60ºC.  This temperature was chosen 
because it has been shown to have  a 6-log reduction when used alone , as well shown complete 
eradication of biofilm when used with a cocktail of antibiotics (68, 75). This temperature has been 
reported to be within the clinically safe range as several studies with bone cement and drilling in 
bone have shown that curing temperatures of bone cement and drilling in cortical bone readily 







After biofilms had grown on the washers, they were gently rinsed with 300µL sterile saline 
before being exposed to a pulsed electromagnetic field (PEMF) with a maximum of 1800 watts at 
27 kHz to evaluate the relationship between alternating magnetic field (AMF) exposure and 
bacterial survival. An identical control washer that did not have a surface associated biofilm, was 
used for each the stainless steel and titanium washers as a control to monitor the temperature during 
heating. All discs were heated up to and then maintained at 60ºC for the specific times indicated 
for each experiment.   
 
 
Figure 2 - Sterilized washers placed into the wells of a 12 well tissue culture plate. 
 
2.3.3. Bacterial Enumeration 
 
Washers containing biofilms that had either been heated using the PEMF, or non-heated 
control samples were placed into 13mL snap cap tubes with 3mL of sterile saline. These samples 
were then sonicated using a probe sonicator (Misonix XL2020) to disrupt the biofilms but did not 






Sonication is the application of ultrasonic energy to a sample immersed in a fluid (the 
sonicate fluid) to dislodge biofilm embedded bacteria. Through this process, the sensitivity of 
cultured samples is improved. The efficiency of sonication to achieve dislodgment of bacteria 
from biofilm on titanium or stainless steel implants has been shown to be superior to scraping with 
a surgical blade (88).  
 These samples were then serially diluted and 10µL drops were plated in duplicate on 
tryptic soy agar (TSA) plates, which were incubated at 37ºC overnight to determine the number of 
















2.3.4 Temperature Measurement 
 
Washers were placed the wells of a sterile plastic dish that was designed such that each 
well would receive identical levels of heat from the induction cooktop. A control washer of the 
same material as those being heated was placed into one of the wells and a calibrated thermometer 
(thermocouple) was used in order to constantly measure the temperature of the control washer. 
The control temperature readings were used as feedback to deactivate heating when the washers 
reached the target temperature and then reactive heating as soon as the washer dropped below the 
target temperature in order to keep the temperature constant.  Figure 4 shows the arrangement of 
the induction system and images of a heated washers. Our study was limited by the physical 
characteristics of the heater and washers and as such, the maximum temperature that could be 
reliably reached and maintained for the implants was 60°C. Notably, this temperature has 
previously been shown to have inhibitory effects in a planktonic heating mode. Pijls et al. (70) 
grew a S. aureus biofilm model on titanium alloy cylinders and exposed to incremental target 
temperatures (35°C, 45°C, 50°C, 55°C, 60°C, 65°C, 70°C) for up to 3.5 minutes with NCIH and 








  Fig. 4 Photograph of the arrangement of the induction systems, washers on a modified platform; with 
temperature data logging with laptop; IH- Inductiotion heater ; TC – Thermocouple Temperature sensor ;  DL 
– Data logger ( Laptop) , CP- Custom petridish 
 
2.3.5 Effect of Temperature and Duration 
The washers were initially exposed to maximum target temperature of 60°C for 3.5, 10 and 
15 minutes. The initial  duration of 3.5 minutes was chosen from results in published studies with 
food products which revealed that 3.5 minutes caused at least a 3-log reduction of bacteria (66). 
Pijls et al. (68)  showed an effect of a more than 6-log reduction for 2.5, 3.0 and 3.5 minutes at 
60°C, additionally total eradication of the biofilm has been reported with induction heating at 60°C 
at 3.5 min with subsequently exposure to cocktails of vancomycin, rifampicin and NAC (75). 
Furthermore, to test the effect of longer heat treatments, washers were maintained at 60ºC for 10 
and 15 minutes before plating to enumerate any viable bacteria that remained. Washers that were 
heated for the various times were compared to control washers that were not exposed to the PEMF. 
 
2.3.6 Effect of Vancomycin 
In a clinical setting, intravenous vancomycin is the drug of choice for most MRSA 
infections seen in hospitalized patients. It can be used both as empiric and definitive therapy as 
most MRSA infections are susceptible to vancomycin. The dosage depends upon the type and 
severity of the infection. Vancomycin trough is obtained just before the fourth dose to ascertain a 
therapeutic level. The goal trough range typically is between 10 and 20 ug/mL. For complicated 
infections, the goal is between 15 and 20 ug/mL. Vancomycin and daptomycin are considered 
adequate empiric therapy according to the Infectious Diseases Society of America guidelines of 






may not respond adequately to vancomycin. Therefore, in these cases, daptomycin is a better 
option (5). 
 Hence in order to determine if heating the biofilm resulted in increased sensitivity to 
vancomycin, we conducted the following series of experiments.( Table 1 ) Washers that had been 
heated for 10 minutes as previously described were then placed back into new 12 well plates 
containing sterile TSB with vancomycin added at 2 or 20ug/mL. These concentrations were chosen 
as they are sufficient to kill planktonic S. aureus, in vitro and fall within the normal concentration 
range of intravenous vancomycin therapy for infected patients in vivo (5). 
After a 24-hour incubation with vancomycin, the washers were sonicated and plated for 
CFUs as described above. These washers were compared to both control washers that were heated 
and then put into fresh media with no vancomycin, and control washers that were not heated but 
were exposed to the same concentration of vancomycin to determine if there was any synergistic 




    Time Duration              Vancomycin (Conct.) 
 3.5 10 15 (Low)2ug/mL (High)20ug/mL 
S.S washers + + + + *(Pending) 
Titanium + + + *(Pending) + 







2.3.7 In Vitro Growth Analysis 
Data was graphed and analyzed using GraphPad Prism V7.0 (GraphPad Software, La Jolla, 
CA). Data points are presented as the mean +/- standard deviation for at least 3 biological replicates 
from a minimum of 2 independent experiments. Statistical significance determined by a one-way 
ANOVA with Dunnetts multiple comparison * P<0.05, ** P<0.01, *** P<0.001. 
 
Chapter 3- Results  
3.1 Biofilm grown on washers  
To initially explore the effects of heat and antibiotics for the treatment of biofilm-based 
implant infections, the first requirement was establishing the ability to grow biofilms on metal 
implants. To do this, we used an S. aureus, in vitro biofilm model using strain USA300 grown in 
the presence of stainless-steel & titanium washers ( N= 3 in each group over 2 independent 
experiments). Bacteria were grown on the washers within sterile culture plates using TSB (tryptic 
soy broth) growth media with or without the addition of 0.4 % glucose. This method has previously 
been demonstrated by Lim et al., to stimulate biofilm formation (89). After growth the washers 
were rinsed with sterile saline to remove any non-adhered bacteria before sonicating and plating. 
It was found that the control specimens that did not get glucose had approximately 12-fold fewer 
bacteria adhered to the surface of the washers than those grown in the presence of glucose. This 
confirmed that the addition of 0.4% glucose to TSB is an effective method for establishing adherent 








Figure 5 – The ability of S. aureus to form an adherent biofilm on stainless-steel washers. S. aureus USA300 
grown in the presence of washers with or without glucose supplementation. Samples were incubated statically 
for 24 hours before being washed then sonicated and plated to determine the number of adherent CFUs. Data 
shown as the mean +/- SD and statistical significance was determined by an unpaired T-test where * P<0.05. 
N=3   
 
3.2 Tested effects of Vancomycin treatment on pre-formed biofilm 
The next objective was to confirm that biofilm formation leads to increased antibiotic 
resistance. To this end, vancomycin, which is typically used clinically to treat MRSA infections, 
was added to the culture media after the biofilms had been grown on the washers. Vancomycin 
was added at 2µg/mL, double the concentration previously shown to inhibit the growth of 
planktonic S. aureus USA300, and incubated for another 24 hours before plating, as done before. 
(N=4 for no Vancomycin and N=6 for addition of Vancomycin over 2 independent experiments) 
Twenty-four hours incubation was chosen as it is the accepted standard for S. aureus growth 
experiments and MIC testing is done at 24 hour time intervals (90). Addition of vancomycin lead 






sub-MIC vancomycin use. This confirmed that the biofilms grown on the washers are resistant to 
vancomycin at a concentration known to be effective against planktonic bacteria. This resistance 
to antibiotics necessitates the study of novel methods for treating biofilm-based implant infections 
(Figure 6). 
 
Figure 6 – S. aureus biofilms are resistant to vancomycin treatment. S. aureus USA300 biofilms were grown on 
stainless-steel washers as before, after growth the washers were placed in fresh media either with or without 
2µg/mL vancomycin and incubated for 24 hours before plating. Data are presented as the mean +/- SD with and 
N=4 for -Vanc and N=6 for +Vanc over 2 independent experiments.  
 
3.3 Tested effects of duration of heating ‘Thermal shock’ via induction heating on biofilm  
After establishing an in vitro model of a biofilm with resistance to regular antibiotic 
(vancomycin ) use ,  I sought to study NCIH as a novel method for treating biofilm-based implant 
infections, as recently reported by Pijls et al (68). To analyze the effects of duration of heat 






titanium), with surface-associated biofilms, were heated to and maintained at 60C for different 
time intervals i.e 3.5, 10, 15 minutes ( Stainless steel – N= 3 each , Titanium 5 each). These heated 
washers were then compared to washers that were not exposed to heat to determine the difference 
in bacterial burden. After heating, the stainless-steel washers showed a 24-, 25-, and 48-fold 
reduction (3.5, 10, and 15 minutes respectively) on average in CFU/mL compared to controls. 
However, the titanium washers showed a 5-, 20-, and 24-fold reduction on average compared to 
controls for the same conditions. I did an ANOVA and multiple comparison for the stainless-steel 
washers to compare the 3.5 minutes to 10 minutes and the 10 minutes to the 15 minutes. For the 
3.5 vs 10minutes P=0.997, and for the 10 minute vs 15 minutes P=0.884, which are both non-
significant. For the titanium washers the 3.5 vs 10 minutes P=0.128, the 10 vs 25 minutes P=0.997 
and the 3.5 vs 15 minutes P=0.114. It is worth noting that although the titanium washers had 
smaller decreases in CFU/mL compared to the stainless-steel washers for the same conditions, the 
results were more statistically significant, which is likely due the larger number of replicates for 
the titanium washers. While the bacteria were not eliminated this has shown that biofilm grown on 
stainless steel & titanium washers heated to 60C showed significant reduction in the number of 
bacteria adhered to the surface. Because the differences observed when heating for 10 or 15 
minutes were comparable, the 25 fold vs 48 fold difference is not statistically significant because 
there are only 3 replicates and there is some variation between each of the replicates, 10 minutes 








Figure 7 – Induction heating of mature biofilms grown on stainless steel and titanium washers. USA300 based 
biofilm grown on stainless steel (A) or titanium (B) washers, either exposed to thermal shock of 60C for various 
times or left unheated. Data shown as the mean +/- SD, statistical significance determined by a one-way ANOVA 
with Dunnetts multiple comparison * P<0.05, ** P<0.01, *** P<0.001. In Stainless steel (A) N=5 for the control 
no heat, N=3 each for 3.5/10/15-minute intervals for both groups over 2 independent experiments, in (B) 







3.4 Tested Synergistic effects of low dose Vancomycin after thermal Shock (Stainless steel 
washers) 
The next objective was to determine whether there is a synergistic effect of vancomycin 
treatment after an initial thermal shock to the biofilm. As a control (N=5) to establish the starting 
number of CFUs in the biofilms, plating was done for a group of washers before heating, then the 
remaining washers with biofilms were heated at 60ºC for 10 minutes, as mentioned before. Again, 
stain less steel washers (N=5) were selected and plated to determine level of killing by thermal 
shock alone, while the remaining washers that were heated, were then put into fresh media with or 
without vancomycin (2µg/mL) and incubated for 24 hours before plating ( N=5 washers for “no 
heat” and “heated” groups, N=3washers for “Heat+Vancomycin” and “Heat-Vancomycin, for all 
other samples over 2 independent experiments).This concentration was chosen to represent 
clinically relevant concentrations (91). It was found that the vancomycin (low dose) treatment after 
thermal shock still had no effect and the number of CFUs in the biofilm actually increased, 
matching the sample that had no vancomycin exposure. Therefore, while the heat causes 
significant levels of bacterial death it did not restore planktonic levels of antibiotic sensitivity and 










Figure 8 –Vancomycin (2µg/mL) is not effective against biofilms on stainless steel washers even after heating -
USA300 biofilms grown on stainless steel washers exposed either to thermal shock (60oC, 10minutes) alone, or 
in combination with a secondary 24-hour incubation with or without vancomycin (2µg/mL). Data shown as the 
mean +/- SD for N=5 for “no heat” and “heated”, N=3 for “Heat+Vanc” and “Heat-Vanc” Statistical 







3.5 Tested Synergistic effects of higher dose Vancomycin at (20µg/mL) after thermal shock 
(titanium washers) 
Since induction heat with low dose of vancomycin concentration did not show significant 
decrease in CFU/ml , a similar set of experiments were repeated on titanium washers with a higher 
concentration(20µg/mL ) of vancomycin (higher range of serum concentrations in IV therapy) 
making it a clinically relevant concentration. As before, washers were selected (N= 3 titanium 
washers in each group) before and after heating (60ºC, 10 minutes) to be plated as controls, and 
the remaining samples that were heated were incubated in media with or without vancomycin 
(20µg/mL) before plating.. There was a 20-fold decrease in CFU/ml after initial effect of thermal 
shock, but then another 50-fold decrease for the washers receiving both the heat and then the high 
dose vancomycin treatment for 24-hours. This dual treatment resulted in a ~1000-fold total 
decrease in CFUs compared to untreated controls. This suggests that although the bacteria were 
not eliminated there is a potential synergistic effect between the heat and antibiotic treatment 









Figure 9-Vancomycin (20µg/mL) is effective against biofilms on titanium washers after heating. USA300 based 
biofilm grown on titanium washers plated before & after exposure to thermal shock of 60C for 10 minutes. 






as mean +/- SD for N=3, statistical significance determined by a one-way ANOVA with a Dunnetts multiple 
comparison where * P<0.05, ** P<0.01, *** P<0.001. 
 
3.6 – Series of experiments pending due to interruptions caused by COVID-19 
We had planned on the following experiments to better elucidate the relationship between 
heating and antibiotics on both stainless steel and titanium washers, but the lab was closed because 
of COVID-19. List of pending / possible future series of experiments include - 
1. Testing of Synergistic effect on 
• Heat + (high concentration) Vancomycin on Stainless Steel washers 
• Heat + (low concentration) Vancomycin on Titanium washers 
2. Independent effect of (high cont.) Vancomycin on biofilm grown on Stainless steel 
+ Titanium washers, (non-heated – control group) 
3.  Synergistic use of antibiotic cocktail (eg. Vancomycin, Rifampicin / NAC) 
4.  Replicate series of experiments in different species (eg. S. epidermidis) 
 
Chapter 4 -Discussion and future directions 
 
The effects of antibiotics and antimicrobial agents on bacterial biofilm infections have 
received significant attention in the literature (86, 92). As strategies based on antibiotics typically 
have shown to fail in the treatment of infected implants, the physical and mechanical properties of 
biofilms, need to be researched as potential therapeutic targets. The physical methods that have 






To establish the scope of potential role of physical methods, such as heat, we have 
investigated the impact of heat treatment and its synergistic effects with antibiotic therapy on 
stainless steel and titanium orthopedic implants (washers). Stainless steel and commercially pure 
titanium are widely used materials in orthopedic implants. Stainless steel is the most frequently 
used material in orthopedics because of its mechanical strength, low costs, and the possibility of 
bending and shaping the implant to create a custom fit in the operating room. However, major 
disadvantages of stainless steel are well-documented: surface corrosion phenomena and the high 
rate of locally and systemically released corrosion products (95), which led many authors to 
recommend the use of titanium for orthopedic implantation as an ‘bio-inert’ material (96). But 
neither of the materials  has been termed the ‘golden standard’ material in general (97). 
The results of our study show that non-contact induction heating of orthopedic implants 
appears feasible and was effective in vitro, in the reducing the bacterial load for S. aureus biofilm. 
There was a 20-fold decrease in CFU/ml after initial effect of thermal shock, and then another 50-
fold decrease for the washers receiving both the heat and then the high dose vancomycin treatment 
for 24 hours. But complete eradication was not observed.  
Periprosthetic joint infection (PJI) is the leading cause of revision surgery, and is the most 
challenging complication after total joint replacement (98). It is essential to have a multi-
disciplinary approach between microbiologists, surgeons, and infectious disease departments to 
yield the best outcome in these challenging situations (16). There are many management strategies 
and protocols to treat PJI, which need to be individualized to each patient to maximize success. 
This can be in the form of antibiotic suppression; debridement with retention of prosthesis (DAIR) 
(10, 11), or excision arthroplasty including single-stage revision (11), two-stage revision;(12) 






The majority of present treatment strategies are maximally invasive; therefore, challenging 
in patients with high comorbidities. The current gold stand of 2 stage revision surgery still cannot 
treat 15-20% infections at 5 years (99).  Hirakawa et al. (100) reported that reimplantation was 
successful in 80.0% of knees with low-virulence organisms (coagulase-negative Staphylococcus, 
Streptococcus), 71.4% with polymicrobial organisms, and 66.7% with high-virulence organisms 
(methicillin-resistant Staphylococcus aureus) (100). Furthermore, the increasing antibiotic 
resistance of bacteria raises concern and limits the choices of antibiotics(58, 59). Therefore, it is 
vital that novel, non-invasive management options such as non-contact induction heating of 
metallic implants for the prevention and treatment of biofilm infections in implants are developed 
to reduce the burden of more invasive and extensive revision surgeries and possibly improve 
effectiveness of present standard of care practices. 
In our study, non-contact induction heating for 10 minutes at 60°C, on contaminated 
stainless steel & titanium washers showed an average of 25- and 20-fold reduction in CFU/ml of 
bacteria yield, respectively. Notably titanium washers had smaller decreases in CFU/mL compared 
to the stainless-steel washers for the same conditions, the results were more statistically significant, 
which is likely due the larger number of replicates for the titanium washers. Titanium may 
demonstrate some bacteriostatic properties with a varying degree to different types of micro-
organisms (101).  These results were comparable with a similar in-vitro study done by Pijls et al 
which reported a 6-log reduction of bacterial load on titanium discs by using PEMF induction 
heating at 60°C for 3.5 minutes (68).  
In our study, the synergistical use of the dual treatment strategy (heat and antibiotics) 
resulted in a ~1000-fold total decrease in CFUs/ml. Suggests the potential synergistic effect 






completely eliminated , Hajdu et al (74). have also reported on the significant increased 
antibacterial activity of antimicrobials agents by increasing the ambient temperatures of heating 
and using high concentration of antibiotics. They reported that the moderate increase in the 
incubation temperature to 45°C resulted in a decrease in biofilm thickness with treatment with 
different antibiotics (daptomycin, tigecycline, fosfomycin, cefamandole and vancomycin) and 
showed significant reductions in bacterial growth with high antimicrobial concentrations. As 
compared to Hajdu et al.(74) , we did not incubate with antibiotics at higher temperatures, since  
we heated the washers and then put them  in antibiotics at 37°C.  Pickering et al.(102) reported 
that PEMF may work synergistically with thermal shock and increased the effectiveness of 
gentamicin against the five-day biofilms of S. epidermidis, hence  it may be of value in the 
treatment of biofilm-associated implant-related infections. Since our planned set of experiments 
were delayed due to restriction of COVID-19, we could not test for different cocktails of antibiotics 
or different strains of Staphylococcus. 
In our series of experiments, to observe the effects of Sub MIC dose of vancomycin on pre-
formed biofilm, addition of vancomycin at 2µg/mL lead to a higher CFU/mL. This could possibly 
be due to some contamination or dilution error. This ‘close to the mic’ concentration may have an 
effect on the bacteria, which in response to this lower concentration of vancomycin, could change 
their surface structure and actually cause more biofilm to form. Another possible reason that could 
have led to higher CFU/ml rather than contamination could be that sub-MIC vancomycin can 
induce biofilm formation. Sub MIC vancomycin  has been reported to cause biofilm formation 
(103).  Sub-MIC (2ug/mL) which is 2x Planktonic MIC but is below the MIC for biofilms, was 
added to pregrown biofilms, so it was sub-biofilm-MIC vancomycin and may have made more 






interruptions caused due to COVID-19, further testing could not be done. We would need more 
experiments to prove that theory.  
In our experiment, we were unable to show complete eradication of bacteria. Pijls et al. 
(75), reported a total eradication of biofilm on titanium implants at 60 C, with a combination 
induction heating, cocktail of antibiotics (vancomycin , rifampicin) and NAC. The possible 
mechanism of this synergistical effect has been reported by them is that PEMF together with eddy 
currents may interfere with the transport of charged molecules within the bacteria, at the implant 
surface possibly making them more susceptible to thermal shock. Furthermore, with induction 
heating the heat originated on the biofilm-implant interface, travels into the biofilm, whereas the 
antibiotics diffuses into the biofilm starting at the outer border of the biofilm and ultimately ending 
at the biofilm implant interface. This attack from two directions may be a mechanism for the 
observed synergistic effect.   
The major advantage of induction heating of metallic implants is that only the metallic 
implant is actively heated while induction heating has no direct heating effect on the surrounding 
tissue. The surrounding tissue is heated to some extent by thermal conduction from the heated 
metal, but if the tissue is well perfused by arterial and venous blood flow, the heat will very likely 
be significantly reduced as in coagulation procedures (81). Multiple concerns for potential tissue 
necrosis with induction heating due to relatively high temperatures at the prosthesis -bone interface 
may arise. However, animal model studies by Muller et al.(71) demonstrated evidence of a lack of 
thermal necrosis by heating a nickel-titanium shape intramedullary rod in the femur of rats at 40°C 
to 60°C using induction heating and demonstrated no necrosis of the surrounding bone and tissue. 
Furthermore ,clinically relevant studies  using  drilling in bone and bone cement, which achieves 






drilling in cortical bone readily exceed 60°C (78, 82, 83). Additionally, Pijls et al.(79) reported 
heating techniques such as segmental induction heating, which can be used to apply localized 
heating to a segment of an implant, using the remainder of the implant as a heat sink. Hence the 
chosen temperature of 60°C is within the safe temperature range. 
Various limitations exist regarding non-contact temperature control. The temperature 
sensor such as the one used in our experiments cannot be readily used in clinical situations because 
of the absence of direct contact, there is tissue and bone between the implant and the sensor. Cheng 
et al. (104) developed a non-invasive temperature safety system, using  remote acoustic sensing, 
to detect sounds associated with boiling on the implant-tissue interface. Multiple studies regarding 
hip Implants with temperature measurement sensors  have been reported (105). Future research to 
address these challenges might involve developing clinically relevant and safe implants with 
temperature sensors. 
Furthermore, our experiments were in vitro and may not translate entirely to in vivo 
situations with possibility of more mature biofilms. Hyperthermia can have varying physiological 
and molecular effects. Localized hyperthermia has been shown to increase blood flow and vessel 
permeability, which could result in better availability of antibiotics, which could be helpful in 
relieving the infection (106). 
The future clinical application of non-contact induction heating can be used in an operative 
or non-operative situation as part of a multi-modality treatment plan. The non-operative 
application of NCIH can be used in clinical situations as an adjuvant to chronic suppressive 
antibiotic therapy or severely immunocompromised patients, who are not fit for surgery. The metal 
implant fixed to the bone can be heated noninvasively with care taken to avoid excessive heating 






standard therapy, i.e. revision 2 stage surgery cannot completely treat 15-20% infections (99), the 
noninvasive application of induction heating may be particularly beneficial in patients for whom 
surgical treatment is not possible and receive suppression antibiotic therapy.  
Alternatively, NCIH can be used during surgery to increase the effectiveness of the 
surgical procedure such as in debridement, antibiotics and implant retention (DAIR). 
Allowing heating of parts of the implant that cannot be reached and mechanically cleaned. 
During surgery, soft tissue can be protected by keeping it away from the heated part of the 
implant. Additionally, surgery allows for direct temperature control by direct temperature 
measurement (e.g., thermocouple) or by IR thermal imaging.  
Future work needs to be done to find the ideal conditions of heat antibiotic use and 
applications as well as potential for implant related modifications. Further directions for implants 
related modifications include, development of anti-biofilm agents, used as a coating to implants 
to counteract bacterial adhesion. Surface treatment by natural or modified polysaccharide 
polymers with  anti-adhesive and bactericidal coatings has been reported to be a promising 
means to fight against implant-associated biofilm infections(107). 
Preliminary results support the hypothesis that NCIH of stainless steel and titanium 
implants, is effective in reducing bacterial load of S. aureus within a biofilm in vitro. There was 
a 20-fold decrease in CFU/ml after initial effect of thermal shock, and another 50-fold decrease 
for the washers receiving both the heat and then the high dose vancomycin treatment for 24 
hours.  
This Dual treatment resulted in a ~1000-fold total decrease in CFUs compared to untreated 
controls. (~ 3 log reduction). Combined effect of heat and use of antibiotics was seen, but complete 






to restriction imposed due to COVID-19, we could not further test for different combinations 
cocktails of antibiotics or different strains of Staphylococcus.  
  In conclusion non-contact induction heating of metallic (orthopedic) implants appears 
feasible and was effective in vitro, in the reducing the bacterial load for S. aureus biofilm 
Furthermore use of vancomycin, after the thermal shock showed a synergistic effect, leading to a 




1. Parsek MR, Singh PK. Bacterial biofilms: an emerging link to disease pathogenesis. Annu 
Rev Microbiol. 2003;57:677-701. 
2. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, et al. Risk and 
outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-
carriers. Lancet. 2004;364(9435):703-5. 
3. Ellis MW, Schlett CD, Millar EV, Crawford KB, Cui T, Lanier JB, et al. Prevalence of nasal 
colonization and strain concordance in patients with community-associated Staphylococcus 
aureus skin and soft-tissue infections. Infect Control Hosp Epidemiol. 2014;35(10):1251-6. 
4. Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus 
infection. Clin Infect Dis. 2008;46 Suppl 5:S350-9. 
5. StatPearls. 2020. 
6. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-
resistant Staphylococcus aureus. Lancet. 2010;375(9725):1557-68. 
7. Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA. Periprosthetic joint infection. 
Lancet. 2016;387(10016):386-94. 
8. Springer BD, Cahue S, Etkin CD, Lewallen DG, McGrory BJ. Infection burden in total hip 
and knee arthroplasties: an international registry-based perspective. Arthroplast Today. 
2017;3(2):137-40. 
9. Zmistowski B, Karam JA, Durinka JB, Casper DS, Parvizi J. Periprosthetic joint infection 
increases the risk of one-year mortality. J Bone Joint Surg Am. 2013;95(24):2177-84. 
10. Brandt CM, Sistrunk WW, Duffy MC, Hanssen AD, Steckelberg JM, Ilstrup DM, et al. 
Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis 






11. Klouche S, Lhotellier L, Mamoudy P. Infected total hip arthroplasty treated by an 
irrigation-debridement/component retention protocol. A prospective study in a 12-case series 
with minimum 2 years' follow-up. Orthop Traumatol Surg Res. 2011;97(2):134-8. 
12. Kini SG, Gabr A, Das R, Sukeik M, Haddad FS. Two-stage Revision for Periprosthetic Hip 
and Knee Joint Infections. Open Orthop J. 2016;10:579-88. 
13. El-Husseiny M, Haddad FS. The Role of Highly Selective Implant Retention in the Infected 
Hip Arthroplasty. Clin Orthop Relat Res. 2016;474(10):2157-63. 
14. Mahmud T, Lyons MC, Naudie DD, Macdonald SJ, McCalden RW. Assessing the gold 
standard: a review of 253 two-stage revisions for infected TKA. Clin Orthop Relat Res. 
2012;470(10):2730-6. 
15. Tsaras G, Osmon DR, Mabry T, Lahr B, St Sauveur J, Yawn B, et al. Incidence, secular 
trends, and outcomes of prosthetic joint infection: a population-based study, olmsted county, 
Minnesota, 1969-2007. Infect Control Hosp Epidemiol. 2012;33(12):1207-12. 
16. Ibrahim MS, Raja S, Khan MA, Haddad FS. A multidisciplinary team approach to two-
stage revision for the infected hip replacement: a minimum five-year follow-up study. Bone 
Joint J. 2014;96-B(10):1312-8. 
17. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis 
and management of prosthetic joint infection: clinical practice guidelines by the Infectious 
Diseases Society of America. Clin Infect Dis. 2013;56(1):e1-e25. 
18. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and 
knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 
2007;89(4):780-5. 
19. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 
2004;351(16):1645-54. 
20. Williams DL, Taylor NB, Epperson RT, Rothberg DL. Flash autoclave settings may 
influence eradication but not presence of well-established biofilms on orthopaedic implant 
material. J Orthop Res. 2018;36(5):1543-50. 
21. Saeed K, McLaren AC, Schwarz EM, Antoci V, Arnold WV, Chen AF, et al. 2018 
international consensus meeting on musculoskeletal infection: Summary from the biofilm 
workgroup and consensus on biofilm related musculoskeletal infections. J Orthop Res. 
2019;37(5):1007-17. 
22. Kathju S, Nistico L, Melton-Kreft R, Lasko LA, Stoodley P. Direct demonstration of 
bacterial biofilms on prosthetic mesh after ventral herniorrhaphy. Surg Infect (Larchmt). 
2015;16(1):45-53. 
23. Ibrahim MS, Ryan S, Seyler T, Arnold WV, Stoodley P, Haddad F. Infection in 
Arthroplasty: The Basic Science of Bacterial Biofilms in Its Pathogenesis, Diagnosis, Treatment, 
and Prevention. Instr Course Lect. 2020;69:229-42. 
24. Lister JL, Horswill AR. Staphylococcus aureus biofilms: recent developments in biofilm 
dispersal. Front Cell Infect Microbiol. 2014;4:178. 
25. Foster TJ, Geoghegan JA, Ganesh VK, Höök M. Adhesion, invasion and evasion: the many 







26. Geoghegan JA, Corrigan RM, Gruszka DT, Speziale P, O'Gara JP, Potts JR, et al. Role of 
surface protein SasG in biofilm formation by Staphylococcus aureus. J Bacteriol. 
2010;192(21):5663-73. 
27. Abraham NM, Jefferson KK. Staphylococcus aureus clumping factor B mediates biofilm 
formation in the absence of calcium. Microbiology. 2012;158(Pt 6):1504-12. 
28. Swearingen MC, DiBartola AC, Dusane D, Granger J, Stoodley P. 16S rRNA analysis 
provides evidence of biofilms on all components of three infected periprosthetic knees 
including permanent braided suture. Pathog Dis. 2016;74(7). 
29. Ehrlich GD, Hu FZ, Sotereanos N, Sewicke J, Parvizi J, Nara PL, et al. What role do 
periodontal pathogens play in osteoarthritis and periprosthetic joint infections of the knee? J 
Appl Biomater Funct Mater. 2014;12(1):13-20. 
30. Baker P, Hill PJ, Snarr BD, Alnabelseya N, Pestrak MJ, Lee MJ, et al. Exopolysaccharide 
biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas 
aeruginosa biofilms. Sci Adv. 2016;2(5):e1501632. 
31. Schwartz K, Syed AK, Stephenson RE, Rickard AH, Boles BR. Functional amyloids 
composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms. PLoS Pathog. 
2012;8(6):e1002744. 
32. Nishitani K, Sutipornpalangkul W, de Mesy Bentley KL, Varrone JJ, Bello-Irizarry SN, Ito 
H, et al. Quantifying the natural history of biofilm formation in vivo during the establishment of 
chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical 
pathogen and host factors. J Orthop Res. 2015;33(9):1311-9. 
33. O'Gara JP. ica and beyond: biofilm mechanisms and regulation in Staphylococcus 
epidermidis and Staphylococcus aureus. FEMS Microbiol Lett. 2007;270(2):179-88. 
34. Toledo-Arana A, Merino N, Vergara-Irigaray M, Débarbouillé M, Penadés JR, Lasa I. 
Staphylococcus aureus develops an alternative, ica-independent biofilm in the absence of the 
arlRS two-component system. J Bacteriol. 2005;187(15):5318-29. 
35. Brooks JL, Jefferson KK. Phase variation of poly-N-acetylglucosamine expression in 
Staphylococcus aureus. PLoS Pathog. 2014;10(7):e1004292. 
36. Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, et al. 
Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of 
Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee 
joint infections. Biomaterials. 2007;28(9):1711-20. 
37. Mann EE, Rice KC, Boles BR, Endres JL, Ranjit D, Chandramohan L, et al. Modulation of 
eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS One. 
2009;4(6):e5822. 
38. Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. Quorum sensing in Staphylococcus 
aureus biofilms. J Bacteriol. 2004;186(6):1838-50. 
39. Ji G, Beavis R, Novick RP. Bacterial interference caused by autoinducing peptide variants. 
Science. 1997;276(5321):2027-30. 
40. Vuong C, Saenz HL, Götz F, Otto M. Impact of the agr quorum-sensing system on 
adherence to polystyrene in Staphylococcus aureus. J Infect Dis. 2000;182(6):1688-93. 







42. Regassa LB, Novick RP, Betley MJ. Glucose and nonmaintained pH decrease expression 
of the accessory gene regulator (agr) in Staphylococcus aureus. Infect Immun. 1992;60(8):3381-
8. 
43. Koseki H, Yonekura A, Shida T, Yoda I, Horiuchi H, Morinaga Y, et al. Early staphylococcal 
biofilm formation on solid orthopaedic implant materials: in vitro study. PLoS One. 
2014;9(10):e107588. 
44. Otto M. Staphylococcal infections: mechanisms of biofilm maturation and detachment 
as critical determinants of pathogenicity. Annu Rev Med. 2013;64:175-88. 
45. Antoci V, Adams CS, Parvizi J, Ducheyne P, Shapiro IM, Hickok NJ. Covalently attached 
vancomycin provides a nanoscale antibacterial surface. Clin Orthop Relat Res. 2007;461:81-7. 
46. Herrmann M, Vaudaux PE, Pittet D, Auckenthaler R, Lew PD, Schumacher-Perdreau F, et 
al. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal 
isolates to foreign material. J Infect Dis. 1988;158(4):693-701. 
47. Wood TK, Knabel SJ, Kwan BW. Bacterial persister cell formation and dormancy. Appl 
Environ Microbiol. 2013;79(23):7116-21. 
48. Rothenberg AC, Wilson AE, Hayes JP, O'Malley MJ, Klatt BA. Sonication of Arthroplasty 
Implants Improves Accuracy of Periprosthetic Joint Infection Cultures. Clin Orthop Relat Res. 
2017;475(7):1827-36. 
49. Mariani BD, Martin DS, Levine MJ, Booth RE, Tuan RS. The Coventry Award. Polymerase 
chain reaction detection of bacterial infection in total knee arthroplasty. Clin Orthop Relat Res. 
1996(331):11-22. 
50. Higuera CA, Zmistowski B, Malcom T, Barsoum WK, Sporer SM, Mommsen P, et al. 
Synovial Fluid Cell Count for Diagnosis of Chronic Periprosthetic Hip Infection. J Bone Joint Surg 
Am. 2017;99(9):753-9. 
51. Parvizi J, Jacovides C, Antoci V, Ghanem E. Diagnosis of periprosthetic joint infection: the 
utility of a simple yet unappreciated enzyme. J Bone Joint Surg Am. 2011;93(24):2242-8. 
52. Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J. Combined 
measurement of synovial fluid α-Defensin and C-reactive protein levels: highly accurate for 
diagnosing periprosthetic joint infection. J Bone Joint Surg Am. 2014;96(17):1439-45. 
53. Shahi A, Kheir MM, Tarabichi M, Hosseinzadeh HRS, Tan TL, Parvizi J. Serum D-Dimer 
Test Is Promising for the Diagnosis of Periprosthetic Joint Infection and Timing of 
Reimplantation. J Bone Joint Surg Am. 2017;99(17):1419-27. 
54. Klemm K. [Gentamicin-PMMA-beads in treating bone and soft tissue infections (author's 
transl)]. Zentralbl Chir. 1979;104(14):934-42. 
55. Rao N, Ziran BH, Lipsky BA. Treating osteomyelitis: antibiotics and surgery. Plast 
Reconstr Surg. 2011;127 Suppl 1:177S-87S. 
56. Wininger DA, Fass RJ. Antibiotic-impregnated cement and beads for orthopedic 
infections. Antimicrob Agents Chemother. 1996;40(12):2675-9. 
57. Levin PD. The effectiveness of various antibiotics in methyl methacrylate. J Bone Joint 
Surg Br. 1975;57(2):234-7. 
58. Anguita-Alonso P, Hanssen AD, Osmon DR, Trampuz A, Steckelberg JM, Patel R. High 
rate of aminoglycoside resistance among staphylococci causing prosthetic joint infection. Clin 






59. Ravi S, Zhu M, Luey C, Young SW. Antibiotic resistance in early periprosthetic joint 
infection. ANZ J Surg. 2016;86(12):1014-8. 
60. Mah TF. Biofilm-specific antibiotic resistance. Future Microbiol. 2012;7(9):1061-72. 
61. Ciofu O, Tolker-Nielsen T, Jensen P, Wang H, Høiby N. Antimicrobial resistance, 
respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients. Adv 
Drug Deliv Rev. 2015;85:7-23. 
62. Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ. Molecular mechanisms of 
antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42-51. 
63. Doroshenko N, Tseng BS, Howlin RP, Deacon J, Wharton JA, Thurner PJ, et al. 
Extracellular DNA impedes the transport of vancomycin in Staphylococcus epidermidis biofilms 
preexposed to subinhibitory concentrations of vancomycin. Antimicrob Agents Chemother. 
2014;58(12):7273-82. 
64. Kaplan JB. Antibiotic-induced biofilm formation. Int J Artif Organs. 2011;34(9):737-51. 
65. Jørgensen KM, Wassermann T, Jensen P, Hengzuang W, Molin S, Høiby N, et al. 
Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin 
resistance during long-term experimental evolution of Pseudomonas aeruginosa. Antimicrob 
Agents Chemother. 2013;57(9):4215-21. 
66. Kennedy J, Blair IS, McDowell DA, Bolton DJ. An investigation of the thermal inactivation 
of Staphylococcus aureus and the potential for increased thermotolerance as a result of chilled 
storage. J Appl Microbiol. 2005;99(5):1229-35. 
67. Pavlovsky L, Sturtevant RA, Younger JG, Solomon MJ. Effects of temperature on the 
morphological, polymeric, and mechanical properties of Staphylococcus epidermidis bacterial 
biofilms. Langmuir. 2015;31(6):2036-42. 
68. Pijls BG, Sanders IMJG, Kuijper EJ, Nelissen RGHH. Non-contact electromagnetic 
induction heating for eradicating bacteria and yeasts on biomaterials and possible relevance to 
orthopaedic implant infections:. Bone Joint Res. 2017;6(5):323-30. 
69. Chopra R, Shaikh S, Chatzinoff Y, Munaweera I, Cheng B, Daly SM, et al. Employing high-
frequency alternating magnetic fields for the non-invasive treatment of prosthetic joint 
infections. Sci Rep. 2017;7(1):7520. 
70. Huang CF, Chao HY, Chang HH, Lin XZ. A magnetic induction heating system with multi-
cascaded coils and adjustable magnetic circuit for hyperthermia. Electromagn Biol Med. 
2016;35(1):59-64. 
71. Müller CW, ElKashef T, Pfeifer R, Decker S, Neunaber C, Meier K, et al. Transcutaneous 
electromagnetic induction heating of an intramedullary nickel-titanium shape memory implant. 
Int Orthop. 2014;38(12):2551-7. 
72. Urish KL, DeMuth PW, Craft DW, Haider H, Davis CM. Pulse lavage is inadequate at 
removal of biofilm from the surface of total knee arthroplasty materials. J Arthroplasty. 
2014;29(6):1128-32. 
73. Gomes DM, Ward KE, LaPlante KL. Clinical implications of vancomycin heteroresistant 
and intermediately susceptible Staphylococcus aureus. Pharmacotherapy. 2015;35(4):424-32. 
74. Hajdu S, Holinka J, Reichmann S, Hirschl AM, Graninger W, Presterl E. Increased 
temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, 







75. Pijls BG, Sanders IMJG, Kuijper EJ, Nelissen RGHH. Synergy between induction heating, 
antibiotics, and. Int J Hyperthermia. 2020;37(1):130-6. 
76. Karunakar MA, Frankenburg EP, Le TT, Hall J. The thermal effects of intramedullary 
reaming. J Orthop Trauma. 2004;18(10):674-9. 
77. Pape HC, Giannoudis P. The biological and physiological effects of intramedullary 
reaming. J Bone Joint Surg Br. 2007;89(11):1421-6. 
78. Samara E, Moriarty TF, Decosterd LA, Richards RG, Gautier E, Wahl P. Antibiotic stability 
over six weeks in aqueous solution at body temperature with and without heat treatment that 
mimics the curing of bone cement. Bone Joint Res. 2017;6(5):296-306. 
79. Pijls BG, Sanders IMJG, Kuijper EJ, Nelissen RGHH. Segmental induction heating of 
orthopaedic metal implants. Bone Joint Res. 2018;7(11):609-19. 
80. Tillotson CL, Rosenberg AE, Rosenthal DI. Controlled thermal injury of bone. Report of a 
percutaneous technique using radiofrequency electrode and generator. Invest Radiol. 
1989;24(11):888-92. 
81. de Berg JC, Pattynama PM, Obermann WR, Bode PJ, Vielvoye GJ, Taminiau AH. 
Percutaneous computed-tomography-guided thermocoagulation for osteoid osteomas. Lancet. 
1995;346(8971):350-1. 
82. Matthews LS, Hirsch C. Temperatures measured in human cortical bone when drilling. J 
Bone Joint Surg Am. 1972;54(2):297-308. 
83. Deramond H, Wright NT, Belkoff SM. Temperature elevation caused by bone cement 
polymerization during vertebroplasty. Bone. 1999;25(2 Suppl):17S-21S. 
84. Olsen I. Biofilm-specific antibiotic tolerance and resistance. Eur J Clin Microbiol Infect 
Dis. 2015;34(5):877-86. 
85. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, et al. Complete genome 
sequence of USA300, an epidemic clone of community-acquired meticillin-resistant 
Staphylococcus aureus. Lancet. 2006;367(9512):731-9. 
86. Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME. Staphylococcus 
aureus biofilms: properties, regulation, and roles in human disease. Virulence. 2011;2(5):445-
59. 
87. Miyakoshi J, Horiuchi E, Nakahara T, Sakurai T. Magnetic fields generated by an 
induction heating (IH) cook top do not cause genotoxicity in vitro. Bioelectromagnetics. 
2007;28(7):529-37. 
88. Bjerkan G, Witsø E, Bergh K. Sonication is superior to scraping for retrieval of bacteria in 
biofilm on titanium and steel surfaces in vitro. Acta Orthop. 2009;80(2):245-50. 
89. Lim Y, Jana M, Luong TT, Lee CY. Control of glucose- and NaCl-induced biofilm formation 
by rbf in Staphylococcus aureus. J Bacteriol. 2004;186(3):722-9. 
90. Kennedy AD, Porcella SF, Martens C, Whitney AR, Braughton KR, Chen L, et al. Complete 
nucleotide sequence analysis of plasmids in strains of Staphylococcus aureus clone USA300 
reveals a high level of identity among isolates with closely related core genome sequences. J 
Clin Microbiol. 2010;48(12):4504-11. 
91. Thabit AK, Fatani DF, Bamakhrama MS, Barnawi OA, Basudan LO, Alhejaili SF. Antibiotic 
penetration into bone and joints: An updated review. Int J Infect Dis. 2019;81:128-36. 
92. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural 






93. Kumar CG, Anand SK. Significance of microbial biofilms in food industry: a review. Int J 
Food Microbiol. 1998;42(1-2):9-27. 
94. Qian Z, Sagers RD, Pitt WG. The effect of ultrasonic frequency upon enhanced killing of 
P. aeruginosa biofilms. Ann Biomed Eng. 1997;25(1):69-76. 
95. Case CP, Langkamer VG, James C, Palmer MR, Kemp AJ, Heap PF, et al. Widespread 
dissemination of metal debris from implants. J Bone Joint Surg Br. 1994;76(5):701-12. 
96. Steinemann SG. Metal implants and surface reactions. Injury. 1996;27 Suppl 3:SC16-22. 
97. Krischak GD, Gebhard F, Mohr W, Krivan V, Ignatius A, Beck A, et al. Difference in 
metallic wear distribution released from commercially pure titanium compared with stainless 
steel plates. Arch Orthop Trauma Surg. 2004;124(2):104-13. 
98. Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after 
total hip arthroplasty in the Medicare population. J Arthroplasty. 2009;24(6 Suppl):105-9. 
99. Cochran AR, Ong KL, Lau E, Mont MA, Malkani AL. Risk of Reinfection After Treatment of 
Infected Total Knee Arthroplasty. J Arthroplasty. 2016;31(9 Suppl):156-61. 
100. Hirakawa K, Stulberg BN, Wilde AH, Bauer TW, Secic M. Results of 2-stage 
reimplantation for infected total knee arthroplasty. J Arthroplasty. 1998;13(1):22-8. 
101. Li D, Li B, Wang Q, Hou N, Li C, Cheng X. Toxicity of TiO₂ nanoparticle to denitrifying 
strain CFY1 and the impact on microbial community structures in activated sludge. 
Chemosphere. 2016;144:1334-41. 
102. Pickering SA, Bayston R, Scammell BE. Electromagnetic augmentation of antibiotic 
efficacy in infection of orthopaedic implants. J Bone Joint Surg Br. 2003;85(4):588-93. 
103. Cerca N, Martins S, Pier GB, Oliveira R, Azeredo J. The relationship between inhibition of 
bacterial adhesion to a solid surface by sub-MICs of antibiotics and subsequent development of 
a biofilm. Res Microbiol. 2005;156(5-6):650-5. 
104. Cheng B, Chatzinoff Y, Szczepanski D, Bing C, Shaikh S, Wyman O, et al. Remote acoustic 
sensing as a safety mechanism during exposure of metal implants to alternating magnetic 
fields. PLoS One. 2018;13(5):e0197380. 
105. Damm P, Graichen F, Rohlmann A, Bender A, Bergmann G. Total hip joint prosthesis for 
in vivo measurement of forces and moments. Med Eng Phys. 2010;32(1):95-100. 
106. van den Tempel N, Horsman MR, Kanaar R. Improving efficacy of hyperthermia in 
oncology by exploiting biological mechanisms. Int J Hyperthermia. 2016;32(4):446-54. 









                                       Curriculum vitae 
 
Rajeshwar Singh Sidhu (Roger)      
 M.B.B.S, M.S (Orthopedics) (India) 
 
Post-secondary Education and degrees 
*Clinical Fellow - Arthroplasty                                                      1st August 2019 -*31st July2020 
University of Western Ontario, London 
Canada 
 
*MSc Candidate (Master Of Surgery)                                          *1st August 2019 -*31st July 2020 
University of Western Ontario, London 
Canada 
 
Research Fellow - Dept of Sports Medicine                              -1st January 2019 - 31st July 2019 
University of Western Ontario, London 
Canada 
 
Fellowship- Hip & Knee Arthroplasty                                      -1st October 2016- 31st  July 2017 
Indian Society of Hip and Knee Surgeons (ISHKS) Fellowship 
Sparsh Hospital – Bengaluru, India 
Under – Dr. Sharan S. Patil 
Senior registrar                                                                           -1ST April 2016- 30THSeptember 2016 
Trauma & Gen. Orthopedics,  
Sidhu Hospital, Doraha , Punjab , India 
 
 
Residency - M.S (Orthopedics)                                   -  15TH  MARCH 2012- 1ST  APRIL 2015 
Junior Registrar ( Yr 1-Yr 3) 
Jawahar Lal Nehru Medical College 








M.B.B.S                                                                                                15ST JUNE 2006 – 31ST JAN 2012 
(Bachelor of Medicine and Bachelor of Surgery) 
Bharti Vidyapeeth Medical College & Hospital Pune, Maharashtra, India 
 
 
Research Publications  
• Schubert M, Sidhu R, Getgood A, Sherman S. Failures of Realignment Osteotomy. 
Operative techniques in sports medicine. Volume 28, Issue !, March 2020 
● Kooner P, Sidhu R, Grewal R.  Complications of Distal Radius Fractures in the Elderly: A 
systematic review and meta-analysis.  Medical Research Archives 2017;5(4):pg1-4.     
● Sidhu R, Patil S, Ravi M. Conversion Hip Arthroplasty for Failed Hemiarthroplasty: Preventing 
Dislocations.(Indian society of Hip & Knee Surgeons – Fellowship Thesis) 
● Uppin R, Sidhu R, Patil S. The Functional Outcome of Tibial Plateau Fractures (Schatker 
Type V & VI) with Locking Compression Plate. Journal of Orthopaedic Education, Vol. 1 
No. 1, Jan- June 2015 
 
Conference Presentations  
● March 2019 Kooner P, Sidhu R 
“The fragility of statistically significant findings from randomized controlled trials in a premier 
Orthopaedic journal “ 
AAOS Annual meeting , Las vegas, USA (Podium Presentation) 
● Sept 2017 , Kooner P, Sidhu R, Grewal R 
“Complications of Distal Radius Fractures in the Elderly: A systematic review and meta-analysis.” 
San Francisco, USA (Podium Presentation) 
 
● April 2017 , Sidhu R , Patil S , Ravi M 
“ Convertion Hip Arthroplasty for Failed Hemiarthroplasty : Preventing Dislocations                            
Indian Society of Hip and Knee Surgeons Annual National Conference , 
New Delhi , India  ( Podium Presentation ) 
• Feb 2017 , Sidhu R , Patil S , Ravi M 
“ Convertion Hip Arthroplasty for Failed Hemiarthroplasty : Preventing Dislocations 
Karnataka Orthopedic Association Annual State Conference,   







● Aug , 2015 , Sidhu R. , Yammin M. , Sidhu R. 
“Syndesmotic Injuries – Our experience (case series) “ 
Indian Society of Foot and Ankle Surgeons Annual National Conference 
Ludhiana, (Podium Presentation) 
 
● Sept 2014 - Uppin R, Sidhu R, Patil S  
“The Functional Outcome of Tibial Plateau Fractures (Schatzker Type V & VI) with Locking 
Compression Plate” - IOACON  Indian Orthopedic Association conference  
● Bengaluru, India (Poster Presentation) 
 
